Welcome to

Medicines Advice Initiative Australia

Supporting Quality Use of Medicines

Learn More

Current Topic

Heart Failure

February 2025

iStock-1283692146 together through the times (ID 65421)

Medicines for patients with heart failure with reduced ejection fraction (HFrEF)

Heart failure is estimated to affect around 318,000 Australians, with over 60,000 diagnosed every year. The use of recommended medicines is a key factor in reducing hospital admissions and improving survival in people with heart failure with reduced ejection fraction (HFrEF).

Recent Topics

Diabetes Medicines

November 2024

Diabetes is the fastest growing chronic condition in Australia, increasing at a faster rate than other chronic diseases such as heart disease and cancer. It is important to regularly assess the absolute cardiovascular risk and risk of chronic kidney disease (CKD) for all your patients with T2DM.

Read More

Medicines and the Kidneys

August 2024

By stopping and thinking ‘kidney function’ each time you prescribe medicine for someone you suspect of having reduced kidney function, you can identify patients with CKD and ensure their medicines are safe and effective for them.

Read More

Persistent Pain

May 2024

Improving function is a key goal of persistent pain treatment. Achieving this requires patients to engage in self-management strategies built on an understanding of pain that addresses psychological and social factors and minimises use of pain medicines, particularly opioids.

Read More
About MAIA

Medicines Advice Initiative Australia (MAIA) is a consortium dedicated to improving the use of medicines and related health services in Australia.

READ MORE
MAIA-Logo-Full-colour